These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 15389473

  • 1. Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
    Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW, Sahin AA, Arun B, Meric-Bernstam F.
    Cancer; 2004 Nov 01; 101(9):1977-86. PubMed ID: 15389473
    [Abstract] [Full Text] [Related]

  • 2. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
    Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM.
    Ann Surg Oncol; 2009 Oct 01; 16(10):2697-704. PubMed ID: 19653045
    [Abstract] [Full Text] [Related]

  • 3. Should the use of contralateral prophylactic mastectomy be increasing as it is?
    Wood WC.
    Breast; 2009 Oct 01; 18 Suppl 3():S93-5. PubMed ID: 19914552
    [Abstract] [Full Text] [Related]

  • 4. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
    Soran A, Falk J, Bonaventura M, Keenan D, Ahrendt G, Johnson R.
    Ann Surg Oncol; 2007 Feb 01; 14(2):646-51. PubMed ID: 17122987
    [Abstract] [Full Text] [Related]

  • 5. Perceptions of contralateral breast cancer: an overestimation of risk.
    Abbott A, Rueth N, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T.
    Ann Surg Oncol; 2011 Oct 01; 18(11):3129-36. PubMed ID: 21947590
    [Abstract] [Full Text] [Related]

  • 6. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
    Tuttle TM, Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ, Virnig BA.
    J Clin Oncol; 2009 Mar 20; 27(9):1362-7. PubMed ID: 19224844
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R, Carolin K, Wallis T, Visscher DW.
    Hum Pathol; 2003 Mar 20; 34(3):234-9. PubMed ID: 12673557
    [Abstract] [Full Text] [Related]

  • 8. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI, Malone KE, Saltzman BS, Daling JR.
    Cancer; 2006 May 15; 106(10):2104-12. PubMed ID: 16604564
    [Abstract] [Full Text] [Related]

  • 9. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ, Symmans WF, Babiera GV, Singletary SE, Arun B, Sneige N, Pusztai L, Buchholz TA, Sahin A, Hunt KK, Meric-Bernstam F, Ross MI, Ames FC, Kuerer HM.
    Cancer; 2006 Jan 01; 106(1):42-50. PubMed ID: 16333852
    [Abstract] [Full Text] [Related]

  • 10. Contralateral prophylactic mastectomy.
    Rai SS, Mahabir RC, Roberts JW, Song J, Hamid KS, White RR.
    Ann Plast Surg; 2011 Sep 01; 67(3):215-9. PubMed ID: 21508813
    [Abstract] [Full Text] [Related]

  • 11. Clinical and histological predictors of contralateral breast cancer.
    Kollias J, Ellis IO, Elston CW, Blamey RW.
    Eur J Surg Oncol; 1999 Dec 01; 25(6):584-9. PubMed ID: 10556004
    [Abstract] [Full Text] [Related]

  • 12. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
    Chuba PJ, Hamre MR, Yap J, Severson RK, Lucas D, Shamsa F, Aref A.
    J Clin Oncol; 2005 Aug 20; 23(24):5534-41. PubMed ID: 16110014
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
    Herrinton LJ, Barlow WE, Yu O, Geiger AM, Elmore JG, Barton MB, Harris EL, Rolnick S, Pardee R, Husson G, Macedo A, Fletcher SW.
    J Clin Oncol; 2005 Jul 01; 23(19):4275-86. PubMed ID: 15795415
    [Abstract] [Full Text] [Related]

  • 14. Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005.
    McLaughlin CC, Lillquist PP, Edge SB.
    Cancer; 2009 Dec 01; 115(23):5404-12. PubMed ID: 19787635
    [Abstract] [Full Text] [Related]

  • 15. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
    Shahedi K, Emanuelsson M, Wiklund F, Gronberg H.
    Cancer; 2006 Mar 15; 106(6):1237-42. PubMed ID: 16475207
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
    Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB.
    N Engl J Med; 1999 Jan 14; 340(2):77-84. PubMed ID: 9887158
    [Abstract] [Full Text] [Related]

  • 17. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E.
    Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1337-47. PubMed ID: 15817335
    [Abstract] [Full Text] [Related]

  • 18. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution.
    Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM.
    Ann Surg Oncol; 2009 Oct 01; 16(10):2691-6. PubMed ID: 19506956
    [Abstract] [Full Text] [Related]

  • 19. Stratification of breast cancer risk in women with atypia: a Mayo cohort study.
    Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, Maloney SD, Pankratz VS, de Groen PC, Lingle WL, Ghosh K, Penheiter L, Tlsty T, Melton LJ, Reynolds CA, Hartmann LC.
    J Clin Oncol; 2007 Jul 01; 25(19):2671-7. PubMed ID: 17563394
    [Abstract] [Full Text] [Related]

  • 20. Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer.
    Isern AE, Loman N, Malina J, Olsson H, Ringberg A.
    Eur J Surg Oncol; 2008 Oct 01; 34(10):1148-54. PubMed ID: 18434071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.